These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 32753685)
1. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Mahamat-Saleh Y; Aune D; Schlesinger S Sci Rep; 2020 Aug; 10(1):13151. PubMed ID: 32753685 [TBL] [Abstract][Full Text] [Related]
2. Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women. Liang G; Nan H; Qureshi AA; Han J PLoS One; 2012; 7(4):e35211. PubMed ID: 22493740 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community. van der Pols JC; Russell A; Bauer U; Neale RE; Kimlin MG; Green AC J Invest Dermatol; 2013 Mar; 133(3):637-641. PubMed ID: 23076499 [TBL] [Abstract][Full Text] [Related]
4. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Chen GC; Zhang ZL; Wan Z; Wang L; Weber P; Eggersdorfer M; Qin LQ; Zhang W Cancer Causes Control; 2015 Dec; 26(12):1719-28. PubMed ID: 26358829 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D status in adult patients with nonmelanoma skin cancer in Cape Town, South Africa: a cross-sectional study. van Deventer L; Kannenberg SMH; du Toit J Int J Dermatol; 2018 Aug; 57(8):922-927. PubMed ID: 29808911 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis. Caini S; Boniol M; Tosti G; Magi S; Medri M; Stanganelli I; Palli D; Assedi M; Marmol VD; Gandini S Eur J Cancer; 2014 Oct; 50(15):2649-58. PubMed ID: 25087185 [TBL] [Abstract][Full Text] [Related]
7. High serum 25-hydroxyvitamin D concentration in patients with a recent diagnosis of non-melanoma skin cancer: a case-control study. Soares AM; Szejnfeld VL; Enokihara MY; Michalany N; Castro CH Eur J Dermatol; 2018 Oct; 28(5):649-653. PubMed ID: 30355545 [TBL] [Abstract][Full Text] [Related]
8. The Impact of UV-dose, Body Surface Area Exposed and Other Factors on Cutaneous Vitamin D Synthesis Measured as Serum 25(OH)D Concentration: Systematic Review and Meta-analysis. Jager N; Schöpe J; Wagenpfeil S; Bocionek P; Saternus R; Vogt T; Reichrath J Anticancer Res; 2018 Feb; 38(2):1165-1171. PubMed ID: 29374754 [TBL] [Abstract][Full Text] [Related]
9. Dietary antioxidant supplements and risk of keratinocyte cancers in women: a prospective cohort study. Mahamat-Saleh Y; Savoye I; Cervenka I; Al-Rahmoun M; Cadeau C; Boutron-Ruault MC; Kvaskoff M Eur J Nutr; 2022 Aug; 61(5):2825-2836. PubMed ID: 35292856 [TBL] [Abstract][Full Text] [Related]
10. Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: An umbrella review of meta-analyses. Belbasis L; Stefanaki I; Stratigos AJ; Evangelou E J Dermatol Sci; 2016 Dec; 84(3):330-339. PubMed ID: 27663092 [TBL] [Abstract][Full Text] [Related]
11. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. Asgari MM; Tang J; Warton ME; Chren MM; Quesenberry CP; Bikle D; Horst RL; Orentreich N; Vogelman JH; Friedman GD J Invest Dermatol; 2010 May; 130(5):1438-43. PubMed ID: 20043012 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D and skin cancer: a meta-analysis. Gandini S; Raimondi S; Gnagnarella P; Doré JF; Maisonneuve P; Testori A Eur J Cancer; 2009 Mar; 45(4):634-41. PubMed ID: 19008093 [TBL] [Abstract][Full Text] [Related]
13. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Touvier M; Chan DS; Lau R; Aune D; Vieira R; Greenwood DC; Kampman E; Riboli E; Hercberg S; Norat T Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1003-16. PubMed ID: 21378269 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D Intake and Risk of Skin Cancer in US Women and Men. Park SM; Li T; Wu S; Li WQ; Qureshi AA; Cho E PLoS One; 2016; 11(8):e0160308. PubMed ID: 27557122 [TBL] [Abstract][Full Text] [Related]
15. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163 [TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxyvitamin D level, vitamin D intake, and risk of stroke: A dose-response meta-analysis. Shi H; Chen H; Zhang Y; Li J; Fu K; Xue W; Teng W; Tian L Clin Nutr; 2020 Jul; 39(7):2025-2034. PubMed ID: 31530422 [TBL] [Abstract][Full Text] [Related]
17. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study. Afzal S; Nordestgaard BG; Bojesen SE J Invest Dermatol; 2013 Mar; 133(3):629-636. PubMed ID: 23190899 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D level and basal cell carcinoma, squamous cell carcinoma, and melanoma risk. Reddy KK J Invest Dermatol; 2013 Mar; 133(3):589-592. PubMed ID: 23399821 [TBL] [Abstract][Full Text] [Related]
19. Associations of the risk of lung cancer with serum 25-hydroxyvitamin D level and dietary vitamin D intake: A dose-response PRISMA meta-analysis. Wei H; Jing H; Wei Q; Wei G; Heng Z Medicine (Baltimore); 2018 Sep; 97(37):e12282. PubMed ID: 30212966 [TBL] [Abstract][Full Text] [Related]
20. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies. Hu K; Callen DF; Li J; Zheng H Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]